ACI
BDSI

AMP Capital Investors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

AMP Capital Investors’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,590
Closed -$67K – 1092
2021
Q3 		$67K Hold
18,590
– – ﹤0.01% 1101
2021
Q2 		$67K Hold
18,590
– – ﹤0.01% 1150
2021
Q1 		$73K Sell
18,590
-21,444
-54% -$88.6K ﹤0.01% 1204
2020
Q4 		$171K Buy
+40,034
New +$154K ﹤0.01% 1200

Other funds holding BDSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AMP Capital Investors's BDSI Position: Q4 2021 in Review

AMP Capital Investors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2021, closing a stake of 18,590 shares — an estimated $67K sold.

AMP Capital Investors first reported a position in BDSI in Q4 2020 and held it in 4 quarters. The position peaked at $171K in Q4 2020. 156 funds tracked by Wall St. Rank hold BDSI as of Q4 2021.

  • AMP Capital Investors reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 18,590 BioDelivery Sciences International, Inc. shares in Q4 2021, an estimated $67K.
  • AMP Capital Investors first reported a position in BioDelivery Sciences International, Inc. in Q4 2020 and held it in 4 quarters.
  • AMP Capital Investors's BioDelivery Sciences International, Inc. position peaked at $171K in Q4 2020.
  • 156 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.